CPL @1113 (85.5%) on 02-aug-2018 [ "Possible side effects of _" "food interactions with _" "inhibitors include _" "generic name is _" "patient taking _" "Side effects of _" "tablet contains _" "anticholinergic effects of _" "medicines such as _" "possible side effects with _" "possible side effects of _" "patients taking _" "usual doses of _" "antidepressants like _" "doses of _" "Concomitant use of _" "active metabolite of _" "patient receiving _" "drug interactions with _" "you first start taking _" "doctor has prescribed _" "double dose of _" "doctor about _" "inhibitor such as _" "pharmacokinetics of _" "therapy with _" "drugs such as _" "strains of _" "inhibitors including _" "patients were treated with _" "inhibitors such as _" "generic forms of _" "side effects from _" "antidepressant action of _" "Concurrent use of _" "_ is dialyzable" "specific drug interactions with _" "medications include _" "side effects with _" "medicines like _" "_ include drowsiness" "Serious side effects of _" "you stop taking _" "MAO inhibitor such as _" "TENUATE is _" "dosage of _" "side effects of _" "treatment with _" "clinical trials of _" "large dose of _" "you are taking _" "low dose of _" "dose of _" "high doses of _" ] using tranylcypromine
relations
NELL has only weak evidence for items listed in grey